✨ Medicines Consent Notices




21 JANUARY 2010 NEW ZEALAND GAZETTE, No. 3

Product: Carvedilol Tablets 12.5mg
Active Ingredient: Carvedilol 12.5mg
Dosage Form: Tablet
New Zealand Sponsor: Norton Healthcare Limited (NZ Branch Office)
Manufacturer: Teva Pharmaceutical Industries Ltd, Kfar Saba, Israel

Product: Carvedilol Tablets 25mg
Active Ingredient: Carvedilol 25mg
Dosage Form: Tablet
New Zealand Sponsor: Norton Healthcare Limited (NZ Branch Office)
Manufacturer: Teva Pharmaceutical Industries Limited, Kfar Saba, Israel

Product: Carvedilol Tablets 3.125mg
Active Ingredient: Carvedilol 3.125mg
Dosage Form: Tablet
New Zealand Sponsor: Norton Healthcare Limited (NZ Branch Office)
Manufacturer: Teva Pharmaceutical Industries Ltd, Kfar Saba, Israel

Product: Carvedilol Tablets 6.25mg
Active Ingredient: Carvedilol 6.25mg
Dosage Form: Tablet
New Zealand Sponsor: Norton Healthcare Limited (NZ Branch Office)
Manufacturer: Teva Pharmaceutical Industries Ltd, Kfar Saba, Israel

Product: OxyContin
Active Ingredient: Oxycodone hydrochloride 60mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mundipharma New Zealand Limited
Manufacturer: Bard Pharmaceuticals Ltd, Cambridge, United Kingdom

Product: OxyContin
Active Ingredient: Oxycodone hydrochloride 120mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Mundipharma New Zealand Limited
Manufacturer: Bard Pharmaceuticals Ltd, Cambridge, United Kingdom

Product: Pamol Infant Drops (Strawberry Flavour)
Active Ingredient: Paracetamol 50mg/mL
Dosage Form: Oral drops
New Zealand Sponsor: Johnson & Johnson (New Zealand) Limited
Manufacturer: Ensign Laboratories Property Limited, Victoria, Australia

Dated this 15th day of January 2010.

MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go474

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Probenecid-AFT
Active Ingredient: Probenecid 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Probiotec Pharma Property Limited, Victoria, Australia

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 15th day of January 2010.

MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go472



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 3





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
15 January 2010
Medicines, Distribution, Consent, Carvedilol, OxyContin, Pamol
  • MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health

πŸ₯ Provisional Consent to Distribution of New Medicine

πŸ₯ Health & Social Welfare
15 January 2010
Provisional Consent, Medicines, Distribution, Probenecid-AFT
  • MARK RICHARDS, Acting Deputy Director-General, Regulation and Governance Directorate, Ministry of Health